Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  183 results for ""Sodium-Glucose Transporter 2 Inhibitors""

Your Filters

Publisher : oxford university press Subject : biomarkers Subject : diabetes mellitus, type 2 Subject : glucose intolerance Subject : heart failure Subject : insulin-secreting cells Subject : renal insufficiency, chronic
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA.

  • Authors : Mark PB; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.; Sarafidis P

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Renal Insufficiency, Chronic* ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology

  • Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2023 Oct 31; Vol. Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Differential effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose-response meta-analysis involving 10 randomized clinical trials and 71 553 individuals.

  • Authors : Lin DS; Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111, Taiwan.; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei 100, Taiwan.

Subjects: Atherosclerosis* ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control

  • Source: European journal of endocrinology [Eur J Endocrinol] 2023 Jul 20; Vol. 189 (1), pp. S17-S25.Publisher: Oxford University Press Country of Publication: England NLM ID: 9423848 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis.

  • Authors : McEwan P; Health Economics and Outcomes Research Ltd, Cardiff, UK.; Boyce R

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications

  • Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2023 May 04; Vol. Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.

  • Authors : Agarwal R; Richard L. Roudebush VA Medical Center and Indiana University, Indianapolis, IN, USA.; Anker SD

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/drug therapy ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control

  • Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2022 Jun 23; Vol. Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Cardio-renal benefits of sodium-glucose co-transporter 2 inhibitors in heart failure with reduced ejection fraction: mechanisms and clinical evidence.

  • Authors : Aguilar-Gallardo JS; Department of Medicine, Mount Sinai Morningside, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Correa A

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/complications ; Heart Failure*/Heart Failure*/Heart Failure*/diagnosis

  • Source: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2022 May 05; Vol. 8 (3), pp. 311-321.Publisher: Oxford University Press Country of Publication: England NLM ID: 101669491 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Prediction of the effect of dapagliflozin on kidney and heart failure outcomes based on short-term changes in multiple risk markers.

  • Authors : Idzerda NMA; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Stefansson BV

Subjects: Albuminuria/Albuminuria/Albuminuria/*prevention & control ; Benzhydryl Compounds/Benzhydryl Compounds/Benzhydryl Compounds/*therapeutic use ; Biomarkers/Biomarkers/Biomarkers/*blood

  • Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2020 Sep 01; Vol. Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Association between sodium-glucose cotransporter-2 inhibitors and arrhythmic outcomes in patients with diabetes and pre-existing atrial fibrillation.

  • Authors : Fichadiya A; Libin Cardiovascular Institute, Department of Cardiac Sciences, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, T2N 4N1, Calgary, AB, Canada.; Quinn A

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Publisher: Oxford University Press Country of Publication: England NLM ID: 100883649 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial.

  • Authors : Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; The George Institute for Global Health, Sydney, New South Wales, Australia.

Subjects: Benzhydryl Compounds* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glucosides*

  • Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2024 Feb 28; Vol. Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Renal outcomes after contrast exposure in patients with diabetes who use sodium-glucose cotransporter 2 inhibitors.

  • Authors : Chen CW; Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.; Division of Cardiology, Department of Internal Medicine and Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, 110, Taiwan.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects

  • Source: Postgraduate medical journal [Postgrad Med J] 2024 Feb 15; Vol. 100 (1181), pp. 142-150.Publisher: Oxford University Press Country of Publication: England NLM ID: 0234135 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Clinical outcomes with the use of sodium-glucose cotransporter-2 inhibitors in patients with atrial fibrillation and type 2 diabetes mellitus: a multi-centre, real-world cohort study.

  • Authors : Jang J; Division of Cardiology, Department of Internal Medicine, Uijeongbu St.Mary's Hospital, College of Medicine, The Catholic University of Korea, 271 Cheonboro, Uijeongbu, Gyeonggido 11765, South Korea.; Cardiovascular Research Institute for Intractable Disease, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seochogu, Seoul 06591, South Korea.

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/diagnosis ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/epidemiology

  • Source: European journal of preventive cardiology [Eur J Prev Cardiol] 2024 Feb 15; Vol. 31 (3), pp. 320-329.Publisher: Oxford University Press Country of Publication: England NLM ID: 101564430 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  183 results for ""Sodium-Glucose Transporter 2 Inhibitors""